Deiodinase variation and liothyronine treatment interaction to accelerate ECT response in major depression: Pilot data and implications for thyroid pharmacogenomic testing in mood disorders-Reference-Cited by-同舟云学术

Deiodinase variation and liothyronine treatment interaction to accelerate ECT response in major depression: Pilot data and implications for thyroid pharmacogenomic testing in mood disorders

Published:2021-11 Issue: Volume:29-30 Page:100089
ISSN:2468-1717
Container-title:Personalized Medicine in Psychiatry
language:en
Short-container-title:Personalized Medicine in Psychiatry

Author:

Nuñez Nicolas A,Sola Christopher,Kung Simon,Singh Balwinder,Ozerdem Aysegul,Veldic Marin,Croarkin Paul E.,Moore Katherine M.,Betcher Hannah K.,Vande Voort Jennifer L.,Geske Jennifer R.,Biernacka Joanna M.,Rummans Teresa A.,Bahn Rebecca S,Frye Mark A.

Funder

Mayo Foundation

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Neurology (clinical),Clinical Psychology

Reference34 articles.

1. Free T4 index and clinical outcome in patients with depression;Abulseoud;J Affect Disord,2007

2. Group, U.E., Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. The Lancet, 2003. 361(9360): p. 799-808.

3. Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta-analysis;Dierckx;Bipolar Disord,2012

4. Prejudice against ECT: Competition with psychological philosophies as a contribution to its stigma;Fink;J ECT,1997

5. Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial;Kellner;Br J Psychiatry,2010

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of liothyronine supplementation on electroconvulsive therapy-induced cognitive impairment in patients with mood disorders: a clinical trial;INT ARCH HEALTH SCI;2024